SBIR/STTR Research Award
SYNTHESES FOR PRODUCTION OF INOSITOLPHOSPHOLIPIDS
Award amount
$0Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NUTRIMED BIOTECH
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Description: (Applicant's abstract): Inositolphospholipids are an important
group of biological amphiphilic phospholipids. The group includes
phosphatidylinositols (PtdIns) and its radyl and sphingo analogues. Members of
the group are critical intracellular signaling messengers, and important as
biomedical research reagents and for developing diagnostics and therapeutics
based on signaling modalities. Furthermore, inositolphospholipids are
biocompatible amphiphiles with applications in skin-care and intravenous drug
delivery formulations. No practical approach adaptable for economical large
scale production is available.
The overall objective of this investigation is to develop laboratory scale
methods of synthesis, potentially adaptable for economical larger scale
production, for preparing individual molecular species of PtdIns and analogous
inositolphospholipids. During Phase I, a novel approach, applicable to the
entire biological PtdIns group and tailored analogues, was experimentally
validated for PtdIns synthesis, and the structural and stereochemical integrity
of the products was established unequivocally. During Phase II, this approach
to synthesis will be optimized for ultimate economical larger scale production
of PtdIns, and extended to radyl, sphingolipid, thiophosphate and phosphonate
type analogues and selected diastereomers. Further, the approach will be
exploited for the preparation of selected inositolphospholipid molecular
species.
PROPOSED COMMERCIAL APPLICATION:
Not Available
Technology keywords
Not reported